1-1 of 1
Jane Anne Healy
Close
Sort by
Journal Articles

Phase 1-2 Study of Pembrolizumab Combined with the Anti-LAG-3 Antibody MK-4280 for the Treatment of Hematologic Malignancies

Philippe Armand, Pier Luigi Luigi Zinzani, MD, John Palcza, Jane Anne Healy, Akash Nahar, Patricia Marinello, Gareth P Gregory, MBBS (Hons), PhD FRACP, FRCPA
Journal: Blood
Blood (2019) 134 (Supplement_1): 1548.
https://doi.org/10.1182/blood-2019-127474
Published: 2019